Institute for Health Metrics and Evaluation

The Institute for Health Metrics and Evaluation (IHME) is an independent global health research center at the University of Washington that provides rigorous and comparable measurement of the world's most important health problems and evaluates the strategies used to address them. IHME makes this information freely available so that policymakers have the evidence they need to make informed decisions about how to allocate resources to best improve population health.

Todos los conjuntos de datos: C H S
  • C
    • Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years 1990-2016
      diciembre 2018
      Fuente: Institute for Health Metrics and Evaluation
      Subido por: Knoema
      Acceso el: 02 enero, 2019
      Seleccionar base de datos
      Data cited: Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years 1990-2016. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2018.   The Global Burden of Disease Study 2016 (GBD 2016), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 195 countries and territories and at the subnational level for a subset of countries. Estimates for deaths, disability-adjusted life years (DALYs), years lived with disability (YLDs), years of life lost (YLLs), prevalence, and incidence for 29 cancer groups by age and sex for 1990-2016 are available from the GBD Results Tool. Files available in this record are the web tables published in JAMA Oncology in June 2018 in "Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 29 Cancer Groups, 1990 to 2016."
  • H
    • Healthcare Access and Quality Index Based on Amenable Mortality 1990-2016
      diciembre 2018
      Fuente: Institute for Health Metrics and Evaluation
      Subido por: Knoema
      Acceso el: 26 diciembre, 2018
      Seleccionar base de datos
      Global Burden of Disease Study 2016 (GBD 2016) Healthcare Access and Quality Index Based on Amenable Mortality 1990–2016. Global Burden of Disease Study 2016 (GBD 2016) estimates were used in an analysis of personal healthcare access and quality for 195 countries and territories, as well as selected subnational locations, over time. This dataset includes the following global, regional, national, and selected subnational estimates for 1990-2016: age-standardized risk-standardized death rates from 24 non-cancer causes considered amenable to healthcare; age-standardized mortality-to-incidence ratios for 8 cancers considered amenable to healthcare; and the Healthcare Access and Quality (HAQ) Index and individual scores for each of the 32 causes on a scale of 0 to 100. Code used to produce the estimates is also included. Results were published in The Lancet in May 2018 in "Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016
  • S
    • Socio-Demographic Index (SDI) 1950-2019
      octubre 2020
      Fuente: Institute for Health Metrics and Evaluation
      Subido por: Knoema
      Acceso el: 27 octubre, 2020
      Seleccionar base de datos
      Data cited at: Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Socio-Demographic Index (SDI) 1950–2019. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2020.